【All Cosmos Bio-Tech (KY)】Announcement of the Company's Board of Directors' Approval of the Q1 2026 Consolidated Financial Report

1. Date of Board of Directors' resolution or approval: 2026/05/13 2. Date of Audit Committee approval: 2026/05/13 3. Reporting period of financial report or annual self-audited financial information (XXX/XX/XX~XXX/XX/XX): 2026/01/01~2026/03/31 4. Cumulative operating revenue from January 1 to the end of this period (in thousands): 527,663 5. Cumulative operating gross profit (loss) from January 1 to the end of this period (in thousands): 147,176 6. Cumulative operating income (loss) from January 1 to the end of this period (in thousands): 26,408 7. Cumulative net profit (loss) before tax from January 1 to the end of this period (in thousands): 35,978 8. Cumulative net profit (loss) for this period from January 1 to the end of this period (in thousands): 14,708 9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands): 5,266 10. Basic earnings per share (loss) from January 1 to the end of this period (in NTD): 0.08 11. Total assets at period end (in thousands): 4,254,103 12. Total liabilities at period end (in thousands): 818,221 13. Equity attributable to owners of the parent company at period end (in thousands): 2,734,995 14. Other matters that should be stated: None.